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Abstract
Mycobacterium bolletii infection with band erosion complicating
laparoscopic gastric banding is reported. A 33-year-old man
developed right upper quadrant pain and an epigastric discharg-
ing lesion 4 weeks after revision of gastric banding for morbid
obesity. Investigation revealed band erosion with infection of the
omentum and the abdominal wall. The band was removed and
M. bolleti was isolated and identiﬁed after DNA sequence analy-
sis. To the best of our knowledge, this is the ﬁrst case in which
M. bolletii was isolated from a human omentum after complicated
gastric banding surgery.
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Bariatric surgery is currently the most efﬁcacious and endur-
ing treatment for clinically severe obesity, and the number of
bariatric surgery procedures performed has risen in recent
years. However, complications such as slippage, band ero-
sion, outlet obstruction and port problems have been fre-
quently reported. In Germany, 127 patients (1997–2004)
were analysed retrospectively after laparoscopic gastric
banding. The incidence of postoperative complications was:
gastric perforation, 3.1%; band erosion, 3.1%; band or port
leak, 2.3%; port infection, 5.3%; port dislocation, 6.9% and
pouch dilatation, 16.9% [1]. Reoperation was needed in the
case of band erosion, oesophagitis, pouch dilatation, leakage
from the balloon and oesophageal dilatation. Complications
such as massive gastrointestinal haemorrhage and circulatory
collapse as a result of erosion, recurrent small bowel
obstruction and massive pericardial effusion have been
reported rarely [2–4]. Gastric erosion is one of the late
complications of gastric banding, which requires band
removal [5–7].
The aetiology of erosion remains to be identiﬁed. With
a multidisciplinary team approach and prospective data col-
lection, it has been found that band erosion developed in
24 out of 347 patients (6.8%) who underwent gastric band-
ing [8]. Another study reported that 9.5% of 317 patients
who underwent gastric banding developed band erosion [7].
However, in a larger study where 1496 patients who
underwent gastric banding were monitored for complica-
tions, band erosion was identiﬁed in only 17 patients
(1.13%) [9]. In the present study, we report for the ﬁrst
time the isolation of Mycobacterium bolletii from human
omentum in patients who developed band erosion and
wound discharge 1 month after gastric band replacement
for morbid obesity.
A 33-year-old man presented to the emergency depart-
ment of North Shore University Hospital (New York, NY,
USA) with left upper quadrant abdominal pain and purulent
discharge from an epigastric lesion. On examination, the
patient was afebrile and vital signs were stable. Laboratory
studies, including electrolytes, blood chemistry, complete
blood indices and coagulation proﬁle, were normal. The cul-
ture of a specimen taken from the wound surface yielded
few Pseudomonas aeuroginosa and no coagulase-negative
staphylococci.
A tuberculin skin test was also negative. There was no his-
tory of tuberculosis or drug abuse.
Four years earlier, the patient had undergone gastric
band surgery as a result of morbid obesity. Revision was
performed 4 weeks before the admission. Two days after
admission, the patient underwent endoscopy and diagnostic
laparotomy, which revealed band erosion into the stomach
with band adhesion. Specimens from the infected omentum
and abdominal wall were sent for culture and antibiotic
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susceptibility testing. At postoperative day 4, the patient
was febrile (38.6C) with dehiscence of the abdominal
wound. Dressing changes were performed with packing.
There was purulent, non-odorous discharge. Urine and
blood cultures were negative. An omental culture for fungi
was negative, as was ﬂuorochrome staining for acid-fast
bacteria. However, growth of acid-fast bacilli was detected
in broth; therefore, specimens were sent for further evalu-
ation. Meanwhile, the patient was treated with cefepim and
piperacillin/tazobactam. On day 5 postoperatively, the
patient was afebrile and stable; the wound was dry and
intact with good granulation tissue. Further studies revealed
no fungus after 4 weeks, and no acid-fast bacilli were
detected after 6 weeks. Samples from the omentum and
skin wound were sent to New York State Department of
Health for further testing. M. bolletii was identiﬁed from the
culture after DNA sequence analysis (the secA gene
sequence was analysed and the result was conﬁrmed by
hsp65 sequence analysis; both sequences showed 100%
identity with the corresponding sequences of M. bolletii
strain).
Antibiotic susceptibility testing of nontuberculous myco-
bacteria was not performed at the Department of Health.
Nontuberculous mycobacterial organisms were not known
to be human pathogens until 1950, when patients with non-
tuberculous mycobacteria were reported [10,11]. Most non-
tuberculous mycobacterial organisms have been isolated
from water and soil [12–14]. It has been suggested that most
individuals concerned are infected from the environment.
Chronic pulmonary disease is the most common clinical
entity as a result of nontuberculous mycobacteria, and non-
tuberculous mycobacterial lymphadenitis has been reported
in children [15–17].
Most species of nontuberculous mycobacteria have been
described as a cause of cutaneous disease [18,19]. In addi-
tion, nontuberculous mycobacteria cause chronic granulom-
atous infection in joints and connective tissues and
disseminated infection in immunocompromised patients
[20]. Antibiotics including clarithromycin, ethambutol, rifam-
picin, quinolones, sulpha drugs, clofazimine and doxycycline
or amikacin have been used to treat infections caused by
nontuberculous mycobacteria. Over the last decade, 16S
rRNA gene sequencing has been used to identify more
than 45 new species of nontuberculous mycobacteria.
M. bolletii has been recently described and proposed to
be a Mycobacterium chelonae-abscessus group member,
although there are no reports concerning its isolation
from environmental samples [21,22]. It was found that
M. bolletii sp. nov. was resistant to the quinolones, tetracy-
cline, macrolides and imipenem. Recently, M. bolletii strains
were isolated from four patients with respiratory tract
infections and found to be uniformly resistant to clarithro-
mycin [23].
During recent years, the number of nontuberculous myco-
bacteria reported in various clinical situations has increased
signiﬁcantly as a result of better diagnostic tools [24]. Myco-
bacterium jacuzzii infection has been reported after the inser-
tion of breast implants [25] and 70% of the women
concerned have persistent discharge from the surgical
wounds.
Nontuberculous mycobacteria exist widely in soil and
water and can colonize (as well as cause disease in) many
animal species [26]. Colonization of the skin by environ-
mental mycobacteria and intrasurgical transmission has not
been reported. Outbreaks of disease caused by nontubercu-
lous mycobacteria have become common [27–33]. The fre-
quency of wound infection by nontuberculous mycobacteria
after cosmetic surgery has consistently increased
[27,28,31,31,34–37]. Municipal water supplies are major
reservoirs of mycobacteria [26]. Our case report raises the
possibility of isolation of nontuberculous mycobacteria after
gastric banding.
Because this is the ﬁrst description of a human M. bolletii
isolate from omentum, it is unclear when it infected the
wound and what is the best treatment. In this case, removal
of the gastric band led to rapid improvement, although there
was continued discharge from the wound.
Similar to many other mycobacterial infections, the
one described here was indolent and the patient was
never systemically ill. Although mycobacteria can colonize
wounds, in this case, the organism was isolated from
the sterile peritoneal cavity, with no other pathogens
present.
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Human isolates of Aeromonas possess Shiga
toxin genes (stx1 and stx2) highly similar
to the most virulent gene variants of
Escherichia coli
A. Alperi and M. J. Figueras
Unitat de Microbiologia, Departament de Cie`ncies Me`diques Ba`siques,
Facultat de Medicina i Cie`ncies de la Salut. IISPV. Universitat Rovira i
Virgili, Reus, Spain
Abstract
Strains producing Shiga toxins, encoded by stx1 and stx2 genes,
can cause diarrhoea, haemorrhagic colitis and haemolytic uremic
syndrome. PCR screening of 80 clinical Aeromonas strains
showed that 19 were stx1-positive and only one was positive for
both stx1 and stx2. PCR bands were very faint for some strains
and negative results were obtained after subculturing. The
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